There are several assumptions in that header. The least problematic being is there a need to increase cancer research in rare cancers? As people are dying that’s certainly a ‘yes’ in all cancers and particularly in the subset of ‘rare’.
My wobbly human rights slant pops up at the end, rather than being the centre of the story.
